ArticleHuman vaccines & immunotherapeutics2022

Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report.

Wei-Ling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.